Product Information
PENTAZOCINE-NALOXONE TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $2.0619 per EA under NDC 00591039501. Its NADAC has been published 585 times since Nov 28, 2013.
FDA first approved this application on Jan 21, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; 50 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591039501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074736FDA Approved
1/21/1997
TE Code
AB
On Market Since
5/21/1997
Pharmacological Classes
Price Statistics
The NADAC for PENTAZOCINE-NALOXONE TABLET has been published 585 times since Nov 28, 2013, and over the history we have for it it has risen 104.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0619 per EA |
|---|---|
| All-time high | $2.1945 (Aug 12, 2015) |
| All-time low | $1.0089 (Nov 28, 2013) |
| 52-week high | $2.0619 |
| 52-week low | $1.9526 |
| Median price | $1.9141 |
| Average price | $1.8519 |
| Largest weekly change | +61.0% (Aug 20, 2014) |
| Weeks tracked | 585 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pentazocine hydrochloride and naloxone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pentazocine hydrochloride and naloxone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PENTAZOCINE-NALOXONE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PENTAZOCINE-NALOXONE TABLET, manufactured by Actavis Pharma, Inc., is $2.0619 per EA (NDC 00591039501), effective Sep 30, 2026.
How has the price of PENTAZOCINE-NALOXONE TABLET changed over time?
Over the history we have for it, the NADAC for PENTAZOCINE-NALOXONE TABLET has risen 104.4%. It has been tracked across 585 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PENTAZOCINE-NALOXONE TABLET?
Since Nov 28, 2013, the NADAC for PENTAZOCINE-NALOXONE TABLET has ranged from a low of $1.0089 (Nov 28, 2013) to a high of $2.1945 (Aug 12, 2015), with a median of $1.9141 per EA.
Are there cheaper alternatives to PENTAZOCINE-NALOXONE TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PENTAZOCINE-NALOXONE TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PENTAZOCINE-NALOXONE TABLET?
PENTAZOCINE-NALOXONE TABLET (NDC 00591039501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.